Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I solid tumor trial initiated for KSP inhibitor

Aug. 20, 2002

ARC enters research agreement with McGill University for antisense oligonucleotide therapeutics

Aug. 20, 2002

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Aug. 19, 2002

Enrollment initiated in phase III atamestane trial

Aug. 19, 2002

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Aug. 19, 2002

Novel EGFR inhibitors in early development at Boehringer Ingelheim

Aug. 14, 2002

FDA approves Eloxatin for advanced colorectal cancer

Aug. 14, 2002

ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity

Aug. 14, 2002

VNP-40101M enters phase I trial in leukemia

Aug. 13, 2002

OC-1012 completes phase I trial

Aug. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...